Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Nordic Nanovector ASA ( (DE:8NN) ) has provided an update.
Thor Medical ASA announced the completion of Tranche 2 of its private placement, resulting in Scatec Innovation AS significantly increasing its shareholding in the company. The transaction saw Scatec Innovation AS cross key regulatory thresholds, now holding approximately 26.7% of the company’s shares and voting rights, indicating a stronger influence in the company’s governance and future strategic direction.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier in the radiopharmaceutical industry, specializing in the production of radionuclides, primarily alpha particle emitters, derived from naturally occurring thorium. The company utilizes a proprietary process that avoids irradiation or nuclear reactors, offering an environmentally friendly and cost-efficient solution. Thor Medical is headquartered in Oslo, Norway, and is listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
YTD Price Performance: -10.0%
Average Trading Volume: 5,744
Technical Sentiment Consensus Rating: Hold
Current Market Cap: €59.78M
See more data about 8NN stock on TipRanks’ Stock Analysis page.
